scholarly journals Contribution of gut bacteria to the metabolism of cyanidin 3-glucoside in human microbiota-associated rats

2012 ◽  
Vol 109 (8) ◽  
pp. 1433-1441 ◽  
Author(s):  
Laura Hanske ◽  
Wolfram Engst ◽  
Gunnar Loh ◽  
Silke Sczesny ◽  
Michael Blaut ◽  
...  
Keyword(s):  
Intestinal Bacteria ◽  
Hydroxycinnamic Acid ◽  
Gut Bacteria ◽  
Dihydroxybenzoic Acid ◽  
Human Gut ◽  
Germ Free ◽  
Human Microbiota ◽  
Human Intestinal Bacteria ◽  
The Impact

Cyanidin 3-glucoside (C3G) is one of the major dietary anthocyanins implicated in the prevention of chronic diseases. To evaluate the impact of human intestinal bacteria on the fate of C3G in the host, we studied the metabolism of C3G in human microbiota-associated (HMA) rats in comparison with germ-free (GF) rats. Urine and faeces of the rats were analysed for C3G and its metabolites within 48 h after the application of 92 μmol C3G/kg body weight. In addition, we tested the microbial C3G conversion in vitro by incubating C3G with human faecal slurries and selected human gut bacteria. The HMA rats excreted with faeces a three times higher percentage of unconjugated C3G products and a two times higher percentage of conjugated C3G products than the GF rats. These differences were mainly due to the increased excretion of 3,4-dihydroxybenzoic acid, 2,4,6-trihydroxybenzaldehyde and 2,4,6-trihydroxybenzoic acid. Only the urine of HMA rats contained peonidin and 3-hydroxycinnamic acid and the percentage of conjugated C3G products in the urine was decreased compared with the GF rats. Overall, the presence of intestinal microbiota resulted in a 3·7 % recovery of the C3G dose in HMA rats compared with 1·7 % in GF rats. Human intestinal bacteria rapidly degraded C3G in vitro. Most of the C3G products were also found in the absence of bacteria, but at considerably lower levels. The higher concentrations of phenolic acids observed in the presence of intestinal bacteria may contribute to the proposed beneficial health effects of C3G.

scholarly journals Viral route of infection determines the effect of Drosophila melanogaster gut bacteria on host resistance and tolerance to disease

2021 ◽  
Author(s):  
Miguel Landum ◽  
Marta Salvado Silva ◽  
Nelson Martins ◽  
Luís Teixeira
Keyword(s):  
Drosophila Melanogaster ◽  
Viral Infections ◽  
Systemic Infection ◽  
Lactobacillus Brevis ◽  
Gut Bacteria ◽  
Associated Bacteria ◽  
Germ Free ◽  
Viral Loads ◽  
Route Of Infection ◽  
The Impact

AbstractThe microbial community interacting with a host can modulate the outcome of pathogenic infections. For instance, Wolbachia, one of the most prevalent invertebrate endosymbionts, strongly increases resistance of Drosophila melanogaster and other insect hosts, to many RNA viruses. D. melanogaster is also in continuous association with gut bacteria, whose role in antiviral immunity is poorly characterized. Here we asked how gut-colonizing bacteria impact viral titres and host survival, and how these interact with route of infection or Wolbachia presence. We compared germ-free flies and flies associated with two gut bacteria species recently isolated from wild flies (Acetobacter thailandicus and Lactobacillus brevis). We found that Wolbachia-conferred protection to both DCV or FHV is not affected by the presence or absence of these gut bacteria. Flies carrying A. thailandicus have lower DCV loads than germ-free flies, upon systemic infection, but reduced survival, indicating that these bacteria increase resistance to virus and decrease disease tolerance. Association with L. brevis, alone or in combination with A. thailandicus, did not lead to changes in survival to systemic infection. In contrast to the effect on systemic infection, we did not observe an impact of these bacteria on survival or viral loads after oral infection. Overall, the impact of gut-associated bacteria in resistance and tolerance to viruses was mild, when compared with Wolbachia. These results indicate that the effect of gut-associated bacteria to different viral infections, and different routes of infection, is complex and understanding it requires a detailed characterization of several parameters of infection.

scholarly journals Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid

PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0201073 ◽  
Author(s):  
Samantha Yuille ◽  
Nicole Reichardt ◽  
Suchita Panda ◽  
Hayley Dunbar ◽  
Imke E. Mulder
Keyword(s):  
Histone Deacetylase ◽  
Butyric Acid ◽  
Histone Deacetylase Inhibitors ◽  
Gut Bacteria ◽  
Valeric Acid ◽  
Class I ◽  
Human Gut

scholarly journals The in vitro Effect of Fibers With Different Degrees of Polymerization on Human Gut Bacteria

2020 ◽  
Vol 11 ◽  
Author(s):  
Miao Chen ◽  
Bei Fan ◽  
Shujun Liu ◽  
Khandaker Md Sharif Uddin Imam ◽  
Yingying Xie ◽  
...  
Keyword(s):  
Gut Bacteria ◽  
Human Gut ◽  
Vitro Effect

Deconjugation of bile acids by human intestinal bacteria implanted in germ-free rats

Lipids ◽  
1987 ◽  
Vol 22 (9) ◽  
pp. 669-671 ◽  
Author(s):  
Toshiyuki Chikai ◽  
Hiroyuki Nakao ◽  
Kiyohisa Uchida
Keyword(s):  
Bile Acids ◽  
Intestinal Bacteria ◽  
Germ Free ◽  
Human Intestinal Bacteria

scholarly journals Metabolism of Linoleic Acid by Human Gut Bacteria: Different Routes for Biosynthesis of Conjugated Linoleic Acid

2007 ◽  
Vol 189 (6) ◽  
pp. 2566-2570 ◽  
Author(s):  
Estelle Devillard ◽  
Freda M. McIntosh ◽  
Sylvia H. Duncan ◽  
R. John Wallace
Keyword(s):  
Linoleic Acid ◽  
Conjugated Linoleic Acid ◽  
Vaccenic Acid ◽  
Intestinal Bacteria ◽  
Gut Bacteria ◽  
Human Tissues ◽  
Human Gut ◽  
Gram Positive ◽  
Health Promoting

ABSTRACT A survey of 30 representative strains of human gram-positive intestinal bacteria indicated that Roseburia species were among the most active in metabolizing linoleic acid (cis-9,cis-12-18:2). Different Roseburia spp. formed either vaccenic acid (trans-11-18:1) or a 10-hydroxy-18:1; these compounds are precursors of the health-promoting conjugated linoleic acid cis-9,trans-11-18:2 in human tissues and the intestine, respectively.

scholarly journals The Human Fecal Microbiota Metabolizes Deoxynivalenol and Deoxynivalenol-3-Glucoside and May Be Responsible for Urinary Deepoxy-Deoxynivalenol

2013 ◽  
Vol 79 (6) ◽  
pp. 1821-1825 ◽  
Author(s):  
Silvia W. Gratz ◽  
Gary Duncan ◽  
Anthony J. Richardson
Keyword(s):  
Intestinal Bacteria ◽  
Potential Effect ◽  
Fecal Microbiota ◽  
Farm Animals ◽  
Toxic Metabolite ◽  
Content Type ◽  
Human Intestinal Bacteria ◽  
Liquid Chromatography Tandem Mass ◽  
Plant Metabolite

ABSTRACTDeoxynivalenol (DON) is a potent mycotoxin produced byFusariummolds and affects intestinal nutrient absorption and barrier function in experimental and farm animals. Free DON and the plant metabolite DON-3-β-d-glucoside (D3G) are frequently found in wheat and maize. D3G is stable in the upper human gut, but some human intestinal bacteria release DON from D3Gin vitro. Furthermore, some bacteria derived from animal digestive systems degrade DON to a less toxic metabolite, deepoxy-deoxynivalenol (DOM-1). The metabolism of D3G and DON by the human microbiota has not been fully assessed. We therefore conductedin vitrobatch culture experiments assessing the activity of the human fecal microbiota to release DON from D3G. We also studied detoxification of DON to DOM-1 by the microbiota and its potential effect on urinary DON excretion in humans. Fecal slurry from five volunteers was spiked with DON or D3G and incubated anaerobically (from 1 h to 7 days), and mycotoxins were extracted into acetonitrile. Mycotoxins were detected in fecal extracts and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The fecal microbiota released DON from D3G very efficiently, with hydrolysis peaking after 4 to 6 h. The fecal microbiota from one volunteer transformed DON to DOM-1. Urine from the same volunteer also contained DOM-1 (4.7% of DON), whereas DOM-1 was not detectable in urine from other volunteers. Our results confirm that the fecal microbiota releases DON from its glycosylated form, hence increasing the toxic burden in exposed individuals. Furthermore, this is first evidence that the human fecal microbiota of one volunteer detoxifies DON, resulting in the appearance of DOM-1 in urine.

Sign in / Sign up

Export Citation Format

Share Document